Qilian International Holding Group Limited (BGM) - Net Assets
Based on the latest financial reports, Qilian International Holding Group Limited (BGM) has net assets worth $183.49 Million USD as of March 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($207.39 Million) and total liabilities ($23.90 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of Qilian International Holding Group Limit to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $183.49 Million |
| % of Total Assets | 88.47% |
| Annual Growth Rate | 18.22% |
| 5-Year Change | 52.88% |
| 10-Year Change | N/A |
| Growth Volatility | 34.86 |
Qilian International Holding Group Limited - Net Assets Trend (2017–2024)
This chart illustrates how Qilian International Holding Group Limited's net assets have evolved over time, based on quarterly financial data. Also explore BGM current and non-current assets for the complete picture of this company's asset base.
Annual Net Assets for Qilian International Holding Group Limited (2017–2024)
The table below shows the annual net assets of Qilian International Holding Group Limited from 2017 to 2024. For live valuation and market cap data, see how much is Qilian International Holding Group Limit worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-09-30 | $44.09 Million | -0.58% |
| 2023-09-30 | $44.35 Million | -19.31% |
| 2022-09-30 | $54.96 Million | -3.01% |
| 2021-09-30 | $56.67 Million | +96.48% |
| 2020-09-30 | $28.84 Million | +27.40% |
| 2019-09-30 | $22.64 Million | +27.74% |
| 2018-09-30 | $17.72 Million | +29.76% |
| 2017-09-30 | $13.66 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Qilian International Holding Group Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 42.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (September 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $4.35 Million | 10.18% |
| Common Stock | $59.58K | 0.14% |
| Other Comprehensive Income | $1.92 Million | 4.50% |
| Other Components | $36.41 Million | 85.18% |
| Total Equity | $42.74 Million | 100.00% |
Qilian International Holding Group Limited Competitors by Market Cap
The table below lists competitors of Qilian International Holding Group Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Leading Edge Materials Corp
V:LEM
|
$54.37 Million |
|
MCE Holdings Bhd
KLSE:7004
|
$54.38 Million |
|
Finetechnix. Co.Ltd
KQ:106240
|
$54.39 Million |
|
REDCO PRP GROUP LTD -05
F:8KI
|
$54.40 Million |
|
ABO Group
BR:ABO
|
$54.37 Million |
|
Cheil Grinding
KO:001560
|
$54.34 Million |
|
Aplisens SA
WAR:APN
|
$54.31 Million |
|
DocGo Inc
NASDAQ:DCGO
|
$54.29 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Qilian International Holding Group Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 42,792,133 to 42,743,844, a change of -48,289 (-0.1%).
- Net loss of 1,442,830 reduced equity.
- Other comprehensive income increased equity by 1,498,707.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.44 Million | -3.38% |
| Other Comprehensive Income | $1.50 Million | +3.51% |
| Other Changes | $-104.17K | -0.24% |
| Total Change | $- | -0.11% |
Book Value vs Market Value Analysis
This analysis compares Qilian International Holding Group Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.05x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.19x to 0.05x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-09-30 | $1.61 | $0.30 | x |
| 2018-09-30 | $2.19 | $0.30 | x |
| 2019-09-30 | $2.84 | $0.30 | x |
| 2020-09-30 | $3.73 | $0.30 | x |
| 2021-09-30 | $8.05 | $0.30 | x |
| 2022-09-30 | $7.34 | $0.30 | x |
| 2023-09-30 | $5.92 | $0.30 | x |
| 2024-09-30 | $5.91 | $0.30 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Qilian International Holding Group Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -3.38%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -5.75%
- • Asset Turnover: 0.47x
- • Equity Multiplier: 1.24x
- Recent ROE (-3.38%) is below the historical average (9.84%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 12.58% | 6.28% | 0.68x | 2.97x | $290.45K |
| 2018 | 33.74% | 10.26% | 1.51x | 2.18x | $3.64 Million |
| 2019 | 26.80% | 11.57% | 1.31x | 1.77x | $3.34 Million |
| 2020 | 19.40% | 10.12% | 1.04x | 1.84x | $2.45 Million |
| 2021 | 5.75% | 5.52% | 0.76x | 1.37x | $-2.33 Million |
| 2022 | 2.03% | 1.66% | 1.01x | 1.22x | $-4.23 Million |
| 2023 | -18.18% | -16.74% | 0.91x | 1.20x | $-12.06 Million |
| 2024 | -3.38% | -5.75% | 0.47x | 1.24x | $-5.72 Million |
Industry Comparison
This section compares Qilian International Holding Group Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $236,113,024
- Average return on equity (ROE) among peers: -47.06%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Qilian International Holding Group Limited (BGM) | $183.49 Million | 12.58% | 0.13x | $54.37 Million |
| Aurora Cannabis Inc (ACB) | $602.92 Million | -11.50% | 0.39x | $197.35 Million |
| Akanda Corp (AKAN) | $-3.83 Million | 0.00% | 0.00x | $1.51 Million |
| Akebia Ther (AKBA) | $74.01 Million | -330.87% | 6.15x | $340.21 Million |
| Alkermes Plc (ALKS) | $54.20 Million | -73.99% | 0.03x | $4.62 Billion |
| Amylyx Pharmaceuticals Inc (AMLX) | $-25.36 Million | 0.00% | 0.00x | $1.77 Billion |
| Amphastar P (AMPH) | $639.42 Million | 21.51% | 1.37x | $959.02 Million |
| Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) | $346.79 Million | -104.36% | 9.57x | $3.81 Billion |
| Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) | $344.93 Million | 26.40% | 10.61x | $3.57 Billion |
| Anika Therapeutics Inc (ANIK) | $287.08 Million | 1.44% | 0.21x | $199.00 Million |
| ANI Pharmaceuticals Inc (ANIP) | $40.96 Million | 0.73% | 0.09x | $1.80 Billion |
About Qilian International Holding Group Limited
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufactu… Read more